Showing 1 - 10 of 17
Persistent link: https://www.econbiz.de/10010339642
Persistent link: https://www.econbiz.de/10010414869
Effectively designed market mechanisms may reduce growth in health care spending. In this paper, we study the impact of privatizing the delivery of Medicaid drug benefits on drug spending. Exploiting granular data that allow us to examine drug utilization, we find that drug spending would fall...
Persistent link: https://www.econbiz.de/10012945134
Selective contracting is an increasingly popular tool for reducing healthcare costs, but any savings must be weighed against consumer surplus losses from restricted access. Recently, many prescription drug plans utilize preferred pharmacy networks to reduce drug prices. Our results suggest that...
Persistent link: https://www.econbiz.de/10012851484
Governments contract with private firms to provide a wide range of services. While a large body of previous work has estimated the effects of that contracting, surprisingly little has investigated how those effects vary with the generosity of the contract. In this paper we examine this issue in...
Persistent link: https://www.econbiz.de/10013056590
Persistent link: https://www.econbiz.de/10012655767
We study Medicare's competitive bidding program (CBP) for durable medical equipment (DME). We exploit Medicare claims data to examine both prices and utilization, focusing on continuous positive airway pressure (CPAP) devices to treat sleep apnea. We find that spending falls by 47.2% percent...
Persistent link: https://www.econbiz.de/10012482674
Persistent link: https://www.econbiz.de/10012415052
Persistent link: https://www.econbiz.de/10011654526
Persistent link: https://www.econbiz.de/10011765179